The Combination Product Captisol-Enabled® Budesonide + Azelastine HCl Nasal Spray Provides Significant, Long-lasting Relief of Ocular Allergy Symptoms in Ragweed Allergic Patients Studied in an Environmental Exposure Chamber (EEC)

Mean change from baseline (MCFB) in TOSS was significantly greater from placebo (p < 0.0001) from 40 mins post-dose until session end (10 h) for both Captisol-Enabled® Budesonide + Azelastine [MCFB:-1.3 ± 2.15] and Rhinocort Aqua®/Astelin® [MCFB:-1.3 ± 1.79].Captisol-Enabled® Budesonide + Azelastine provided the same or greater numerical TOSS relief (did not reach statistical difference) than Rhinocort Aqua®/Astelin® for 13/14 time points and longer-lasting relief of Red/Burning eyes for the duration of the study (10 h).